Close this search box.

 Skin Cancer and SRT – Jeff Goldstein Interview

All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer compared to the general population. Transplant patients tend to develop a skin cancer called squamous cell carcinoma (SCC) although many […]

Utilizing the SRT Keloid Treatment To Help Change Lives

The SRT Keloid Treatment helps to change lives. To show you just how effective SRT can be for keloids, we wanted to share the story of a patient who was successfully treated with the SRT-100. Tony Perkins, a teacher from St. Louis, came to Dr. Michael Jones after seeing a number of plastic surgeons for […]

Educating Your Patients on Keloid Removal Success Rates

A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described as an overgrowth of tissue that extends beyond the borders of the original wound, keloids differ from that of hypertrophic […]

Tony Perkins: A Keloid Treatment after Removal Success Story in the Making

Tony Perkins is a public school teacher in St. Louis. Mr. Perkins has suffered with keloids on his neck and torso for 15 years. Although keloids are benign growths, the weight of them has caused neck pain for Tony. He had undergone several surgeries previously and noticed that the keloids would return within a few […]

Skin Cancer and SRT – Jeff Goldstein Interview

Jeff Goldstein is a double lung transplant recipient and a multiple skin cancer survivor. Transplant recipients are immune compromised and has a pre-disposition to skin cancer. As a Floridian, Jeff spent a lot of time out in the Miami sun without sunscreen. Due to the sun exposure leading to skin cancer, Jeff has undergone over […]

NBNA – SRT-100, Game Changer for Keloid Treatment

Dr. Michael H. Gold, a previously featured physician in our Physician Spotlight, has been featured in the Fall 2017 issue of National Black Nurses Association News.  Read the article here. SRT-100, Game Changer for Keloid Treatment Treating keloids is very frustrating, not only for the patient suffering from them, but also for the health care […]

When to Suggest SRT Therapy Over Mohs Surgery

For decades, Mohs surgery has been considered the “gold standard” for the treatment of basal cell carcinomas and squamous cell carcinomas, even for cases where cosmetically important features of the face like the eyes, nose, lips, ears, and scalp are the area being treated. As the incidence of basal cell carcinoma and squamous cell carcinoma […]

Global Keloid Treatment Market to Reach US $4.4 Billion by 2027

The expected increase of keloid scar occurrences, the shift from Mohs surgery as well as developments in advanced cryosurgery and radiation therapy devices will bring about an increase in the demand for keloid treatment. Read more: Global Keloid Treatment Market to Reach US $4.4 Billion by 2027

Should I Get the SRT-100 for My Practice?

Superficial radiation therapy was first used to treat non-melanoma skin cancers, such as basal cell and squamous cell carcinomas, back in the 1970s. For the last few decades, the treatment method fell out of use due to a decline in available machinery. Now, the treatment is making a resurgence as our machine becomes more widespread. […]